Home
AvenCell

AvenCell Market Share Analysis for May 2026

Careers We intend to be at the forefront of an ongoing revolution in hematology and oncology where life-threatening hard-to-treat cancers are combated by using the patient’s own immune system. Working at AvenCell Our teams are science-based and passionate in our shared pursuit of excellence, as we push the boundaries of cancer immunotherapy and CAR-Ts to […]

Industry: N/A

Domainavencell.com

Year Founded--

Employees51 - 200

Annual Revenue--

AvenCell

AvenCell (including company regionals)

avencell.com

See more website traffic and engagement information

Total visits to AvenCell's top domains

Understand AvenCell market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

avencell.com2.4K

See more with Sales Intelligence

Avg. visit duration in AvenCell's top domains

Analyze AvenCell engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

avencell.com00:03:45

See more with Sales Intelligence

Avg. pageviews on AvenCell's top domains

See how AvenCell keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

avencell.com2.18

See more with Sales Intelligence

AvenCell top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by AvenCell

These are the website technologies, by industry, used by AvenCell top domains

Payment & Currencies (8)

Cart Functionality

Content Management System (3)

WordPress

eCommerce (3)

WooCommerce

Widget (3)

Google Maps

More Technologies

11

See all

News & Signals from AvenCell

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAvenCell Europe GmbH will attend event EHA 2026 on Jun 11th '26.AvenCell Therapeutics to Report Phase 1a Results of First-in-Class Switchable Allogeneic CD123 CAR-T Therapy for AML in Late-Breaking Oral Presentation at EHA 2026

NewsViroCell Biologics Ltd partners with AvenCell Europe GmbH.ViroCell Biologics and AvenCell Therapeutics announce retroviral vector manufacturing collaboration to accelerate development of novel allogeneic CAR-T therapies for blood cancers.